Madhura A. Tamhankar, MD
Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
Make an appointmentCall 215-662-8100
Penn Medicine Provider

About me

  • Professor of Ophthalmology at the Hospital of the University of Pennsylvania

Dr. Tamhankar is a Professor of Ophthalmology at the Scheie Eye Institute, University of Pennsylvania. She is fellowship trained in Neuro-ophthalmology and serves as the primary point of contact for referrals from various specialties, including neurosurgery, neurology, endocrinology, rheumatology, and general medicine. She is also the only adult strabismus surgeon at the institute, with a large referral network for strabismus surgery, attracting patients from Philadelphia and its surrounding suburbs. Additionally, she co-leads the thyroid eye disease clinic in collaboration with the oculoplastic service. This clinic is a key referral center for patients seeking medical and surgical treatments for complex thyroid eye disease and those considering participation in clinical trials.

Dr. Tamhankar has research interests in thyroid eye disease and giant cell arteritis.

She is the principal investigator on several industry-sponsored clinical trials exploring new therapies for thyroid eye disease. She collaborates with an international Vasculitis Clinical Research Consortium to study MR imaging in giant cell arteritis and helped develop a standardized imaging protocol and scoring system.

Education and training

  • Medical School: Lokmanya Tilak Municipal Medical College
  • Residency: Nair Hospital
  • Residency: St. Mary's Hospital
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

1153 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
highly professional
November 2025
good service
November 2025
very professional
November 2025
she is great

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Tamhankar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Sollenberger CH, Wu AQ, Scott KW, Tamhankar M, Vaz A, Srinivasan VM. Dynamic intraoperative changes in intracranial pressure during venous stenting. , J Neurointerv Surg, 17(8): 2025,793

Yuanyuan Chen, Taylor Linaburg, Sarah Wang, Gibran Merchant, Tejus Pradeep, Patrick Anthony Augello, Gui-shuang Ying, César A. Briceño, Madhura A. Tamhankar Observational Characterization of the Re-treatment Course of Patients with Thyroid Eye Disease , Journal of Neuro-ophthalmology: 2025

Dogra N, Redmond BV, Lilley S, Johnson BA, Lam BL, Tamhankar M, Feldon SE, Fahrenthold B, Yang J, Huxlin KR, Cavanaugh MR. Vision-related quality of life after unilateral occipital stroke. , Brain Behavior, 14(7): 2024

Tamhankar MA, Raza S, Brutsaert E, Urdániz E, Vainilovich Y, Heyes A, Gildea L, Sales-Sanz M. The burden of illness in thyroid eye disease: current state of the evidence. , Front Ophthalmol(Lausanne)., 5: 2025

Rennie L. Rhee, Girish Bathla, Ryan Rebello, Robert M. Kurtz, Mats Junek, Kenneth J. Warrington, Nader Khalidi, Peter A. Merkel1, Konstanze V. Guggenberger, Madhura A. Tamhankar, Thorsten A. Bley for the Vasculitis Clinical Research Consortium Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group , Rheumatology, 64(5): 2025,2910-2918

Linaburg TJ, Pradeep T, Rinelli B, Chen Y, Chen Y, Ying GS, Briceño CA, Tamhankar M Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients. , Arq Bras Oftalmol, 88(5): 2025,2024-0319

Fahrenthold BK, Cavanaugh MR, Tamhankar M, Lam BL, Feldon SE, Johnson BA, Huxlin KR. Training in Cortically Blinded Fields Appears to Confer Patient-Specific Benefit Against Retinal Thinning , Invest Ophthalmol and Vis Sci, 1(65(4)): 2024,29

Kasi S, Volpe NJ, Pistilli M, Tamhankar MA Effectiveness of Medial Rectus Advancement Alone or in Combination with Resection or Lateral Rectus Recession in the Management of Consecutive Exotropia. , JAAPOS, 17(5): 2013,465-470

Madhura Tamhankar, Brady kwong Maxwell Pistilli Benefits and side effects of prisms in the management of diplopia in adults: a prospective study , Journal of the American Association for Pediatric Ophthalmology and Strabismus. , 25(2): 2021,85.e1-85.e6

Kruszewski AM, Tamhankar MA. Ophthalmic Manifestations of Giant Cell Arteritis , Int Ophthalmol Clin, 63(2): 2023,13-23

View all publications